Senators expand probe of Pfizer, Lilly DTC platforms to include telehealth provider partners
Several months after a group of senators sent letters to Pfizer and Eli Lilly investigating their respective direct-to-consumer telehealth platforms, the lawmakers are now directing similar queries toward several of the platforms’ partners.
Several months after a group of senators sent letters to Pfizer and Eli Lilly investigating their respective direct-to-consumer telehealth platforms, the lawmakers are now directing similar queries toward several of the platforms’ partners.
